Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 15, 2021 11:00 ET | Source: Precipio, Inc.

Precipio Terminates its Equity Line

NEW HAVEN, Conn., June 15, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics Company Precipio, Inc. (NASDAQ: PRPO), announces that as part of management’s review of its current financing arrangements,...
June 08, 2021 10:30 ET | Source: Precipio, Inc.

Precipio Launches HemeScreen® Anemia Panel, a One-of-its-Kind Testing Tool

Laboratories can use this rapid, cost effective test to distinguish malignancy-driven anemia from other causes NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company...
May 14, 2021 16:30 ET | Source: Precipio, Inc.

Precipio Announces Q1-2021 and year-end Shareholder Update Call

NEW HAVEN, Conn., May 14, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q1-2021 corporate update call on Thursday, May 20th at 5:00...
May 10, 2021 10:30 ET | Source: Precipio, Inc.

Precipio Launches New HemeScreen Panel for AML, with an unparalleled 4-hour turnaround-time

NEW HAVEN, Conn., May 10, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has launched a new, four-hour Acute Myeloid Leukemia (AML)...
May 03, 2021 09:30 ET | Source: Precipio, Inc.

Precipio Launches its Rapid COVID-19 Antibody test on Amazon Platform

NEW HAVEN, Conn., May 03, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has successfully launched its COVID-19 rapid antibody test (20...
April 26, 2021 11:00 ET | Source: Precipio, Inc.

Current Signed Customers Expected to Generate $1M Annualized Reported Revenues from Precipio’s HemeScreen POL Offering by Q4-2021

NEW HAVEN, Conn., April 26, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that currently, the contracted annualized revenues from signed customers...
April 05, 2021 09:00 ET | Source: Precipio, Inc.

Precipio Enters Into an At-The -Market (ATM) Financing Arrangement

NEW HAVEN, Conn., April 05, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces a new “At-The-Market” (ATM) financing arrangement that improves its...
March 30, 2021 09:00 ET | Source: Precipio, Inc.

Precipio Announces 95% Annual Growth YoY and 180% Quarterly Growth YoY

FY-2020FY-2019Increase (%)Increase ($)Revenues$6.1M$3.1M↑ 95%↑ $3.0MGross profit$1.2M$0.3M↑ 425%↑ $0.9M Q4-2020Q3-2020 Increase (%)Increase ($)Revenues$1.9M$1.6M↑ 19%↑ $0.3MGross...
March 18, 2021 16:30 ET | Source: Precipio, Inc.

Precipio Announces Q4-2020 and year-end Shareholder Update Call

NEW HAVEN, Conn., March 18, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4-2020 and year end corporate update call on Wednesday,...
March 03, 2021 13:00 ET | Source: Precipio, Inc.

Mr. Ron Andrews joins Precipio’s Board of Directors

NEW HAVEN, Conn., March 03, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that Mr. Ron Andrews has joined the company’s Board of Directors. As...